Journal Mobile Options
Table of Contents
Vol. 221, No. 4, 2010
Issue release date: December 2010
Dermatology 2010;221:296–299

Lichen Planus Occurring after Influenza Vaccination: Report of Three Cases and Review of the Literature

Sato N.A. · Kano Y. · Shiohara T.
Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Although influenza vaccine is thought to be effective and safe, it occasionally causes systemic reactions such as toxic epidermal necrolysis, bullous pemphigoid, lichen planus (LP), etc. The period of increased risk of developing these events was different depending on the immune responses induced by the vaccination. We report 3 cases of LP which appeared after an influenza vaccination. Our cases indicate that the period of increased risk of developing vaccine-related LP was concentrated within 2 weeks after vaccination, and that the vaccine alone represents a triggering factor necessary for immune alteration sufficient for the development of LP. Because these adverse events tend to develop over a predictable time course, the time of onset may give an important clue to the diagnosis of vaccine-related diseases. We suggest that a history of recent vaccination should be sought in all patients presenting with linear LP.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Javanovic M, Poljacki M, Vujanovic L, Duran V: Acute febrile neutrophilic dermatosis (Sweet’s syndrome) after influenza vaccination. J Am Acad Dermatol 2005;52:367–369.

    External Resources

  2. Wolf R, Barzilai A, Davidovici B: Neutrophilic dermatosis of the hands after influenza vaccination. Int J Dermatol 2009;48:66–68.
  3. Tan AW, Tan HH, Lim PL: Bullous Sweet’s syndrome following influenza vaccination in a HIV-infected patient. Int J Dermatol 2006;45:1254–1255.
  4. Mignogna MD, Lo Muzio L, Ruocco E: Pemphigus induction by influenza vaccination. Int J Dermatol 2000;39:800.
  5. de Simone C, Caldarola G, D’agostino M, Zampetti A, Amerio P, Feliciani C: Exacerbation of pemphigus after influenza vaccination. Clin Exp Dermatol 2008;33:718–720.
  6. Downs AM, Lear JT, Bower CP, Kennedy CT: Does influenza vaccination induce bullous pemphigoid? A report of four cases. Br J Dermatol 1998;138:363.
  7. Cambiaghi S, Scarabelli G, Pistritto G, Gelmetti C: Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology 1995;191:340–341.
  8. Tsushima T, Kito Y, Tomita K: Erythema nodosum-like eruption after influenza HA vaccination (in Japanese). Rinsho Hifuka 2006;60:342–345.
  9. Inoue T, Mihara M, Koube N, Kimura R: Toxic epidermal necrolysis after influenza vaccination (in Japanese). Hihu Rinsho 1977;19:1153–1156.
  10. Akay BN, Arslan A, Cekirge S, Erkin G, Anadolu-Brasie R: The first reported case of lichen planus following inactivated influenza vaccination. J Drugs Dermatol 2007;6:536–538.

    External Resources

  11. Eisen DP, McBryde ES: Avoiding Guillan-Barré syndrome following swine origin pandemic H1N1 2009 influenza vaccination. J Infect Dis 2009;200:1627–1628.
  12. Aubin F, Angonin R, Humbert P, Agache P: Lichen planus following hepatitis B vaccination. Arch Dermatol 1994;130:1329–1330.
  13. Ferrando MF, Doutre MS, Beylot-Barry M, Durand I, Beylot C: Lichen planus following hepatitis B vaccination. Br J Dermatol 1998;139:350.
  14. Schupp P, Vente C: Lichen planus following hepatitis B vaccination. Int J Dermatol 1999;38:799–800.
  15. García-Doval D, Mayo E, Nogueira Fariña J, Cruces MJ: Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain. Br J Dermatol 2006;155:820–823.
  16. Shiohara T, Mizukawa Y, Takahashi R, Kano Y: Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. Curr Dir Autoimmun 2008;10:206–226.
  17. Miljkovic J, Belic M, Godic A, Klemenc P, Marin J: Zosteriform lichen planus-like eruption. Acta Dermatovenerol Alp Panonica Adriat 2006;15:94–97.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00